Long-term safety of anti-TNTN F treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection: Commentary

Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)149-150
Number of pages2
JournalInternational Journal of Advances in Rheumatology
Volume8
Issue number4
StatePublished - Dec 1 2010

ASJC Scopus subject areas

  • Rheumatology

Cite this